🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchSurvodutide (GCG/GLP-1) — anyone have experience? Page 2

Survodutide (GCG/GLP-1) — anyone have experience?

stefan_berlin Sat, Mar 28, 2026 at 5:44 AM 16 replies 838 viewsPage 2 of 4
Dr.AddMedPHL
Senior Member
1,234
6,234
Mar 2024
Philadelphia, PA
Mar 28, 2026 at 8:25 PM#6

The figures, for anyone assembling their own picture. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Mar 28, 2026 at 10:25 PM
49 2FitDadDave, RunnerRach, TrialNerd_Beth and 46 others
Reply Quote Save Share Report
pam_columbus
Member
312
1,345
Aug 2024
Columbus, OH
Mar 29, 2026 at 2:15 AM#7

One thing that is still open after Dr.MetabolicMD’s answer:

What would you measure differently if you were starting again?

50 3alex_tucson, kevin_tulsa, Dr.PainCLE and 47 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Mar 29, 2026 at 8:05 AM#8
Dr.AddMedPHL said:
Keep the original post as written when you update it, and add the correction underneath.

Adding the part of the answer the thread has not reached. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Mar 29, 2026 at 2:05 PM
1 4cory_ATX
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
stefan_berlin
Member
234
1,123
Oct 2024
Berlin, DE
Mar 29, 2026 at 1:55 PM#9

OP back with an update, since a thread like this is useless without one.

Coming back a few months on. It held. Nothing dramatic to report, which is the report.

2 5TirzTom, TrialTracker_MD
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Mar 30, 2026 at 5:55 PM#10
Dr.RheumBOS said:
If two explanations both fit, the useful question is which one predicts something the other does not.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

Last edited: Mar 30, 2026 at 11:55 PM
50 0Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 47 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register